Cabio Net Receivables from 2010 to 2025
| 688089 Stock | 18.09 0.25 1.40% |
Net Receivables | First Reported 2019-06-30 | Previous Quarter 244.2 M | Current Value 246.1 M | Quarterly Volatility 56.3 M |
Check Cabio Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabio Biotech's main balance sheet or income statement drivers, such as Tax Provision of 17.8 M, Net Interest Income of 1.7 M or Interest Expense of 856.9 K, as well as many indicators such as . Cabio financial statements analysis is a perfect complement when working with Cabio Biotech Valuation or Volatility modules.
Cabio | Net Receivables |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Cabio Stock
Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.